Skip to main content

Table 1 Baseline clinical and intraoperative characteristics of patients before and after PSM

From: The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis

Variable

Before PSM

After PSM

non-PHT (n = 107)

PHT (n = 102)

P

d

non-PHT (n = 59)

PHT (n = 59)

P

d

Age (yr)

48.5 ± 11.4

49.4 ± 11.2

0.468

−0.080

48.7 ± 12.1

49.1 ± 10.8

0.561

−0.035

>65:<65

11:96

12:90

0.732

−0.083

7:46

5:54

0.542

0.274

Gender (male: female)

91:16

85:17

0.734

0.071

51/8

49/10

0.609

0.145

HBV/No-HBV

101/6

95/7

0.707

0.119

55/4

53/6

0.509

0.244

ALB (g/L)

42.6 ± 4.2

40.7 ± 4.9

0.006

0.417

42.1 ± 4.3

42.1 ± 3.9

0.802

−0.001

TBil (μmol/L)

14.6 ± 5.4

19.5 ± 7.3

<0.001

−0.766

16.6 ± 5.6

17.3 ± 5.8

0.611

−0.123

ALT (U/L)

45.2 ± 24.8

50.6 ± 36.5

0.254

−0.174

50.7 ± 28.5

47.2 ± 23.2

0.891

0.135

AST (U/L)

48.5 ± 25.3

51.1 ± 38.2

0.803

−0.081

48.4 ± 19.0

47.9 ± 22.3

0.675

0.024

WBC (109/L)

6.4 ± 1.6

5.2 ± 2.2

<0.001

0.626

6.4 ± 1.8

5.1 ± 2.1

<0.001

0.665

RBC (1012/L)

4.6 ± 0.7

4.5 ± 0.7

0.402

0.143

4.5 ± 0.7

4.6 ± 0.8

0.515

−0.133

Hemoglobin (g/L)

138.2 ± 19.5

139.2 ± 19.1

0.776

−0.052

138.3 ± 17.8

141.3 ± 19.2

0.385

−0.162

Thrombocyte (109 /L)

189.4 ± 66.6

96.4 ± 42.4

<0.001

1.657

171.4 ± 63.1

97.9 ± 44.6

<0.001

1.3452

Creatinine (μmol/L)

86.2 ± 19.2

79.7 ± 18.9

0.009

0.341

83.6 ± 19.2

80.7 ± 20.4

0.376

0.146

BUN (mmol/L)

5.1 ± 1.2

7.60 ± 2.6

0.663

−1.245

5.2 ± 1.2

5.1 ± 1.4

0.376

0.077

PT (sec)

13.1 ± 1.2

14.2 ± 1.2

<0.001

−0.917

13.7 ± 0.9

13.8 ± 0.9

0.751

−0.111

APTT (sec)

35.4 ± 5.9

54.1 ± 38.6

<0.001

−0.685

37.1 ± 5.6

37.3 ± 6.2

0.946

−0.034

INR

1.00 ± 0.3

1.1 ± 0.1

<0.001

−0.443

1.1 ± 0.1

1.1 ± 0.1

0.530

0.001

Child-Pugh classification (A/B)

105/2

99/3

0.957

0.256

57/2

59/0

0.476

-

MELD score

7.9 ± 1.4

8.8 ± 1.9

<0.001

−0.541

8.2 ± 1.5

8.3 ± 1.6

0.825

−0.065

MELD classification (<9:9–10:>10)

84:15:8

57:20:25

<0.001

−0.547

42:9:8

41:8:10

0.776

 

Size of the tumor (cm)

6.5 ± 3.3

5.3 ± 3.1

0.006

0.375

5.7 ± 3.2

5.5 ± 2.9

0.912

0.066

Vascular invasion(pre: abs)

7:100

15:87

0.055

−0.497

3:56

9:50

0.068

−0.668

Adjacent tissues invasion (pre: abs)

17:90

12:90

0.389

0.192

8:51

9:50

0.793

−0.076

Lymphatic metastasis (pre: abs)

2:105

1:101

1.000

0.361

0

1:58

1.000

-

Number of tumor (1:2:>2)

77:15:15

71:11:20

0.575

−0.104

42:7:10

41:8:10

0.870

−0.022

Extent of hepatectomy (1:2:>2)

46:36:25

55:36:11

0.034

0.319

29:20:10

35:16:8

0.289

0.185

Intraoperative heamorrhage > 400 ml

25

28

0.497

−0.119

8

16

0.067

−0.476

Intraoperative transfusion

20

24

0.391

−0.161

6

11

0.190

−0.389

Pringle maneuver

85

76

0.397

0.154

50

46

0.344

0.249

  1. Continuous variables are reported in mean and standard deviation.
  2. d indicates standardized mean differences.